# Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

> **NCT02336750** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 212 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Mirtazapine

## Key facts

- **NCT ID:** NCT02336750
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2022-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336750, "Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT02336750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*